IFNB1 and melanoma: After 12 hours of stimulation with mrIfn-γ, mouse melanoma clones with Ig2bp1-3 gene knockout expressed significantly higher levels of endogenous interferon beta compared to CRISPR/Cas9 non-targeting controls (Figure 3C).